Specifically, patients harboring a TET2 mutation or experiencing a loss of TET2 functionality are predisposed to an elevated risk of developing various cardiovascular pathologies, such as atherosclerosis (25), pulmonary hypertension (23), aortic valve stenosis, and heart failure (26, 27). Here, TET2 is linked to pulmonary arterial hypertension.